South Africa Hopes New Bill Brings Traditional Knowledge Protection 17/05/2012 by Linda Daniels for Intellectual Property Watch 4 Comments The Intellectual Property Laws Amendment Bill currently in the in-tray of South African President Jacob Zuma and awaiting a signature, holds the hope that it will finally pave the way for the protection of the country’s most famous red tea, Rooibos, as well as other local staples.
Book Offers Timely Insights On IP, Drugs And Public Health In Developing Countries 25/04/2012 by Intellectual Property Watch Leave a Comment A recent book comes in time for the international policy debates coming to a head over access to medicines, intellectual property rights and public health in developing countries.
Text Of Kenya Judgment On Anti-Counterfeiting Now Available 23/04/2012 by Intellectual Property Watch Leave a Comment A copy of a key judgment by the High Court of Kenya last week that found a national anti-counterfeiting law was overly broad and might interfere with access to generic medicines is now available on Intellectual Property Watch.
Kenyan High Court’s Overturning Of Anti-Counterfeit Law Hailed 21/04/2012 by Intellectual Property Watch 3 Comments The High Court of Kenya yesterday ruled that the country’s 2008 Anti-Counterfeit Act was too broad and could interfere with the flow of legal generic medicines to patients, leading the UNAIDS organisation to issue a statement praising the decision. It also said intellectual property rights are not more important than life and health, according to UNAIDS.
Trade And Development With A Dash Of IP: Conference To Set Course For UNCTAD 11/04/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment The quadrennial conference of the United Nations Conference on Trade and Development (UNCTAD) sets the course of the UN body work for the next four years. The mandate of the conference has evolved since its creation to become mainly a provider of research, policy analysis and technical assistance to developing countries. This time around, the conference will serve as a wide-ranging forum for trade and development issues, and intellectual property issues will haunt discussions in several areas.
Book Details IP Rights And Development 02/04/2012 by Intellectual Property Watch Leave a Comment Using on-the-ground research in Africa and the Netherlands, the authors of a recent book looked at the impact of intellectual property on agriculture and health in developing countries. The study made some surprise findings in relation to IP and development, such as IP-related obstacles to knowledge and technology transfer.
Global Fund Changes Continue As West Africa Team Leader Departs 23/03/2012 by William New, Intellectual Property Watch 1 Comment The head of the West Africa region for the Global Fund to Fight AIDS, Tuberculosis and Malaria is the next in the line of departures under the organisation’s reforms. On the way out, he sent around a passionate farewell email calling for a dedication to values, and offering a small window on the wrenching transition taking place inside the international organisation.
Nigerian Courts Step Up Against Copyright Piracy: 18 Convicted 21/03/2012 by Intellectual Property Watch 1 Comment The last year has witnessed a series of convictions of copyright pirates by the Federal High Courts in Nigeria. Information provided by Afam Ezekude, the Director General of the Nigerian Copyright Commission, the government agency responsible for copyright matters, shows that the courts have convicted copyright infringers in 18 cases within the last 5 months (October 2011 to February 2012).
A NEW South Africa Traditional Knowledge Bill – Sui Generis Protection for TK 18/03/2012 by Intellectual Property Watch 3 Comments If you cannot beat them, join them. For that reason this Chair of IP has decided to announce a NEW sui generis Protection of Traditional Knowledge Bill in the hope that something may yet be done to save us all.
Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool 14/03/2012 by Intellectual Property Watch Leave a Comment Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.